People | April 29, 2023
Atul appoints Rangaswamy Iyer as Independent Director
The appointment is effective from May 01, 2023 for five years
The appointment is effective from May 01, 2023 for five years
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
The business and product range of Ipca and that of Unichem complements each others business and product range
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Enabling wireless monitoring In ambulances and homes
Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.
Subscribe To Our Newsletter & Stay Updated
